Fact CheckerSign in

NCT06119178Completed

EX-PRESS® P-50 and EX-PRESS® P-200

Source: ClinicalTrials.gov · Last updated 12 Aug 2024

Brief summary (registry, in English)

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term clinical performance and safety outcomes for EX-PRESS Glaucoma Filtration Devices Models P-50 and P-200.

Status (registry)
Completed
Study type
Observational
Enrollment
122 (actual)
First submitted
31 Oct 2023
Start date
21 Nov 2023
Primary completion date
20 Jun 2024
Lead sponsor
Alcon Research
Diseases
Glaucoma
NCT number
NCT06119178

What you commit to

  • Study type: Observational
  • Participants enrolled: 122
  • From 21 Nov 2023 to the primary completion date, 20 Jun 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • At the time of implantation:
    • Presence of ocular disease such as uveitis, ocular infection, severe dry eye, severe blepharitis.
    • Pre-existing ocular or systemic pathology that, in the opinion of the surgeon, is likely to cause postoperative complications following implantation of the device.
    • Diagnosed with angle-closure glaucoma.

Other

  • Enrolled in any clinical trial within the last 5 years;
  • Other protocol-defined exclusion criteria may apply.

Who the study is looking for

  • Able to understand and sign an Institutional Review Board (IRB) / Independent Ethics Committee (IEC) approved informed consent form authorizing data collection prior to the review of any medical records;
  • Implanted (one eye or both) with the EXPRESS P-50 or EXPRESS P-200 device per indications for use for at least 5 years;
  • Have a minimum of 5 years of recorded follow-up data;
  • Other protocol-specified inclusion criteria may apply.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
El Paso Eye Surgeons, PA
Coordinator of this site? Confirm its status
El PasoUnited StatesUnknown status
Boozman Hoff Regional Eye Clinic
Coordinator of this site? Confirm its status
RogersUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.